| Cell migration or cytokinesis and proliferation?–revisiting the “go or grow” hypothesis in cancer cells in vitro T Garay, É Juhász, E Molnár, M Eisenbauer, A Czirók, B Dekan, V László, ... Experimental cell research 319 (20), 3094-3103, 2013 | 131 | 2013 |
| Apelin promotes lymphangiogenesis and lymph node metastasis J Berta, MA Hoda, V Laszlo, A Rozsas, T Garay, S Torok, M Grusch, ... Oncotarget 5 (12), 4426, 2014 | 110 | 2014 |
| Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio-and chemotherapy K Schelch, MA Hoda, T Klikovits, J Münzker, B Ghanim, C Wagner, ... American journal of respiratory and critical care medicine 190 (7), 763-772, 2014 | 73 | 2014 |
| Invasion from a cell aggregate—the roles of active cell motion and mechanical equilibrium A Szabó, K Varga, T Garay, B Hegedűs, A Czirók Physical biology 9 (1), 016010, 2012 | 68 | 2012 |
| Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis D Lötsch, E Steiner, K Holzmann, S Spiegl-Kreinecker, C Pirker, J Hlavaty, ... Oncotarget 4 (11), 1904, 2013 | 65 | 2013 |
| FGF2 and EGF induce epithelial–mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal K Schelch, C Wagner, S Hager, C Pirker, K Siess, E Lang, R Lin, ... Carcinogenesis 39 (4), 534-545, 2018 | 45 | 2018 |
| Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells MA Hoda, J Münzker, B Ghanim, K Schelch, T Klikovits, V Laszlo, E Sahin, ... British journal of cancer 107 (12), 1978-1986, 2012 | 43 | 2012 |
| The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells L Hegedũs, T Garay, E Molnár, K Varga, Á Bilecz, S Török, R Padányi, ... International journal of cancer 140 (12), 2758-2770, 2017 | 39 | 2017 |
| The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma V Laszlo, Z Valko, J Ozsvar, I Kovacs, T Garay, MA Hoda, T Klikovits, ... Journal of Molecular Medicine 97, 231-242, 2019 | 38 | 2019 |
| Cisplatin and pemetrexed activate AXL and AXL inhibitor BGB324 enhances mesothelioma cell death from chemotherapy DB Oien, T Garay, S Eckstein, J Chien Frontiers in pharmacology 8, 970, 2018 | 37 | 2018 |
| Cell type-dependent HIF1 α-mediated effects of hypoxia on proliferation, migration and metastatic potential of human tumor cells E Tátrai, A Bartal, A Gacs, S Paku, I Kenessey, T Garay, B Hegedűs, ... Oncotarget 8 (27), 44498, 2017 | 36 | 2017 |
| Epigenetic down‐regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma V Laszlo, MA Hoda, T Garay, C Pirker, B Ghanim, T Klikovits, YW Dong, ... The Journal of pathology 237 (2), 203-214, 2015 | 33 | 2015 |
| Histone deacetylase inhibitor treatment increases the expression of the plasma membrane Ca2+ pump PMCA4b and inhibits migration of melanoma cells independent of ERK L Hegedűs, R Padányi, J Molnár, K Pászty, K Varga, I Kenessey, ... | 32 | 2017 |
| Long-term vemurafenib exposure induced alterations of cell phenotypes in melanoma: Increased cell migration and its association with EGFR expression E Molnár, T Garay, M Donia, M Baranyi, D Rittler, W Berger, J Tímár, ... International Journal of Molecular Sciences 20 (18), 4484, 2019 | 30 | 2019 |
| Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo V Laszlo, Z Valko, I Kovacs, J Ozsvar, MA Hoda, T Klikovits, D Lakatos, ... Clinical Cancer Research 24 (15), 3729-3740, 2018 | 30 | 2018 |
| Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells T Garay, I Kenessey, E Molnár, É Juhász, A Réti, V Laszlo, A Rózsás, ... PLoS One 10 (2), e0117021, 2015 | 30 | 2015 |
| RIG-I inhibits the MAPK-dependent proliferation of BRAF mutant melanoma cells via MKP-1 A Szabo, T Fekete, G Koncz, BV Kumar, K Pazmandi, Z Foldvari, ... Cellular signalling 28 (5), 335-347, 2016 | 29 | 2016 |
| Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model I Kenessey, Z Kramer, L István, MT Cserepes, T Garay, B Hegedűs, ... Melanoma Research 28 (6), 536-546, 2018 | 28 | 2018 |
| HDAC inhibition induces PD-L1 expression in a novel anaplastic thyroid cancer cell line L Hegedűs, D Rittler, T Garay, P Stockhammer, I Kovács, B Döme, ... Pathology & Oncology Research 26, 2523-2535, 2020 | 24 | 2020 |
| Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells E Molnár, D Rittler, M Baranyi, M Grusch, W Berger, B Döme, J Tóvári, ... BMC cancer 18, 1-11, 2018 | 23 | 2018 |
